Darolutamide is a medication used in the treatment of prostate cancer. After reviewing the provided sources, it is clear that there are specific gastrointestinal side effects associated with darolutamide.

According to the Drug Patent Watch website, gastrointestinal side effects are listed as common adverse reactions to darolutamide. These side effects may include nausea, diarrhea, and decreased appetite [1].

The Mayo Clinic's webpage on darolutamide also mentions gastrointestinal side effects. It states that diarrhea is a common side effect of this medication. Additionally, it mentions that other gastrointestinal symptoms such as nausea, vomiting, and abdominal pain may occur [2].

A study published in the National Center for Biotechnology Information (NCBI) also supports the presence of gastrointestinal side effects with darolutamide. The study found that diarrhea was the most common adverse event reported by patients receiving darolutamide. Other gastrointestinal side effects reported in the study included nausea, vomiting, and abdominal pain [3].

In conclusion, the provided sources confirm that darolutamide can cause gastrointestinal side effects such as nausea, diarrhea, decreased appetite, vomiting, and abdominal pain. If you are experiencing any of these symptoms while taking darolutamide, it is important to consult your healthcare provider for further guidance.

Sources:
[1] Drug Patent Watch: https://www.drugpatentwatch.com/p/tradename/DAROLUTAMIDE
[2] Mayo Clinic: https://www.mayoclinic.org/drugs-supplements/darolutamide-oral-route/side-effects/drg-20470011?p=1
[3] NCBI: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184837/